Ibu-Lysin

Ibuprofen D,l-Lysinate, the active ingredient in Ibu-Lysin, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It is used to relieve pain, reduce fever, and lessen inflammation in a variety of common conditions. GNH USA supplies Ibu-Lysin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibu-Lysin, an NSAID, acts on pain and inflammatory pathways to provide symptomatic relief. - Pain: Relieves mild to moderate pain such as headache, dental pain, menstrual cramps, and musculoskeletal aches. - Fever: Lowers elevated body temperature associated with infections or inflammatory states. - Inflammation: Decreases swelling and discomfort in conditions like osteoarthritis and rheumatoid arthritis.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated blood pressure in some individuals.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer formation. - Severe renal impairment or acute kidney injury. - Hepatic dysfunction with elevated liver enzymes. - Anaphylactic or severe allergic reactions. - Cardiovascular events such as myocardial infarction or stroke. - Blood disorders like thrombocytopenia.

Before using Ibu-Lysin, consider the following precautions: - Renal function: Use with caution in patients with existing kidney disease. - Gastrointestinal risk: Avoid in individuals with a history of ulcers or GI bleeding. - Concomitant anticoagulants: Monitor for increased bleeding tendency. - Dose duration: Employ the lowest effective dose for the shortest necessary period. - Pregnancy and breastfeeding: Consult a healthcare professional before use. - Store at ambient temperature: Keep in the original packaging, protect from moisture and direct sunlight.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may reduce renal function when combined. - Diuretics: potential for renal impairment and electrolyte disturbances.